You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 142 No. 10, October 1982 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (39)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Intravenous Nitroglycerin for Rest Angina

Potential Pathophysiologic Mechanisms of Action

Nicholas Louis DePace, MD; Irving M. Herling, MD; Morris N. Kotler, MD; A-Hamid Hakki, MD; Scott R. Spielman, MD; Bernard L. Segal, MD

Arch Intern Med. 1982;142(10):1806-1809.


Abstract



• Twenty patients with refractory rest angina pectoris were treated with intravenously (IV) administered nitroglycerin (mean dosage, 72.4 µg/min; range, 15 to 226 µg/min). There was a considerable reduction or abolition in the number of ischemic episodes in 85% of patients without overall substantial changes in heart rate, mean arterial BP, pulmonary capillary wedge pressure (PCWP), and pulmonary arterial mean pressure. However, those patients with an initial PCWP of more than 12 mm Hg or a systolic pressure of more than 130 mm Hg had a substantial reduction in PCWP and systolic BP following IV nitroglycerin. We conclude that IV nitroglycerin may relieve rest angina by different pathophysiologic mechanisms. In some patients, IV nitroglycerin favorably altered the hemodynamic determinants of myocardial oxygen consumption. In others, however, no change in these determinants occurred, suggesting a direct effect on the coronary circulation.

(Arch Intern Med 1982;142:1806-1809)



Author Affiliations



From the Likoff Cardiovascular Institute, Hahnemann Medical College and Hospital, Philadelphia.


Footnotes



Accepted for publication June 14, 1982.

Reprint requests to Likoff Cardiovascular Institute, Hahnemann Medical College and Hospital, 230 N Broad St, Philadelphia, PA 19102 (Dr Herling).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chapter 44 Non-ST-elevation acute coronary syndromes
Ardissino et al.
The ESC Textbook of Acute and Intensive Cardiac Care 2010;1:med-9780199584314-chapter-med-9780199584314-chapter.
ABSTRACT | FULL TEXT  

CHAPTER 16 Acute Coronary Syndromes
Hamm et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT | FULL TEXT  

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
Authors/Task Force Members et al.
Eur Heart J 2007;28:1598-1660.
FULL TEXT  

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Bertrand et al.
Eur Heart J 2002;23:1809-1840.
FULL TEXT  

Treatment of Perioperative Myocardial Ischemia
Zvara
SEMIN CARDIOTHORAC VASC ANESTH 2001;5:166-183.
ABSTRACT  

Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation
British Cardiac Society Guidelines and Medical Pra and Royal College of Physicians Clinical Effectiveness
Heart 2001;85:133-142.
FULL TEXT  

Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology: Recommendations of the Task Force of the European Society of Cardiology
Bertrand et al.
Eur Heart J 2000;21:1406-1432.
 

The Role of Nitrates in Coronary Heart Disease
Abrams
Arch Intern Med 1995;155:357-364.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.